期刊
JOURNAL OF CHILD NEUROLOGY
卷 25, 期 3, 页码 393-396出版社
SAGE PUBLICATIONS INC
DOI: 10.1177/0883073809338626
关键词
nonconvulsive status epilepticus; Angelman syndrome; intravenous levetiracetam
Children with Angelman syndrome have an increased risk of developing a nonconvulsive status epilepticus. Although the urgency to treat nonconvulsive status epilepticus depends on the underlying illness, most clinicians and authors agree that treatment should be focused to rapidly terminate this condition. Until now, the use of levetiracetam to treat nonconvulsive status epilepticus in children is based only on some case reports. Our case further supports this treatment regime for a subgroup of children with a special risk of noncolvulsive status epilepticus and developmental delay.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据